STANDEX REPORTS FISCAL FIRST QUARTER 2025 FINANCIAL RESULTS

    --  Sales Declined 7.7% with Contributions from Acquisitions Partially
        Offsetting Organic Decline
    --  Record GAAP and Adjusted Gross Margin of 41.1%; Up 240 bps Sequentially
        and 160 bps YOY
    --  GAAP Operating Margin of 14.1%; Adjusted Operating Margin of 15.9%
    --  Acquired Amran Instrument Transformers & Narayan Powertech Pvt., Ltd.,
        Largest Acquisition in Company's History; Significantly Expands Presence
        in Fast-Growing, High-Margin Electrical Grid End Market; Expected to be
        Immediately Accretive to Revenue Growth, Margins, and EPS

SALEM, N.H., Oct. 29, 2024 /PRNewswire/ -- Standex International Corporation (NYSE: SXI) today reported financial results for the first quarter of fiscal year 2025 ended September 30, 2024.



      Summary Financial Results - Total



     ($M except EPS and Dividends)               1Q25   1Q24    4Q24        Y/Y         Q/Q



     Net Sales                                 $170.5  $184.8   $180.2      -7.7 %      -5.4 %



     Operating Income - GAAP                    $24.1   $26.9    $27.1     -10.5 %     -11.2 %



     Operating Income - Adjusted                $27.0   $29.4    $28.7      -8.0 %      -6.0 %



     Operating Margin % - GAAP                 14.1 % 14.6 %  15.1 %    -50 bps    -100 bps



     Operating Margin % - Adjusted             15.9 % 15.9 %  16.0 %      0 bps     -10 bps



     Net Income from Continuing Ops - GAAP      $18.2   $18.9    $19.7      -3.7 %      -7.6 %



     Net Income from Continuing Ops - Adjusted  $20.3   $20.8    $20.9      -2.3 %      -2.6 %





     EBITDA                                     $31.2   $33.2    $33.9      -5.9 %      -7.9 %



     EBITDA margin                             18.3 % 17.9 %  18.8 %   + 40 bps     -50 bps



     Adjusted EBITDA                            $34.1   $35.6    $35.5      -4.2 %      -3.8 %



     Adjusted EBITDA margin                    20.0 % 19.3 %  19.7 %   + 70 bps    + 30 bps





     Diluted EPS - GAAP                         $1.53   $1.58    $1.66      -3.2 %      -7.8 %



     Diluted EPS - Adjusted                     $1.71   $1.74    $1.76      -1.7 %      -2.8 %



     Dividends per Share                        $0.30   $0.28    $0.30       7.1 %       0.0 %





     Free Cash Flow                             $10.8   $12.1    $22.2     -10.3 %     -51.3 %



     Net Debt to EBITDA                         -0.1x   0.2x    0.0x         NM          NM

First Quarter Fiscal 2025 Results

Commenting on the quarter's results, President and Chief Executive Officer David Dunbar said, "Following record profit and cash generation in fiscal year 2024, we delivered another solid operational performance in the fiscal first quarter with record gross margin. Sales from fast growth markets in electric vehicles, defense applications, and commercialization of space improved year-on-year, respectively, but were offset primarily by demand conditions affecting the soft trim business in our Engraving segment. In the fiscal first quarter, we achieved record gross margin of 41.1% and maintained adjusted operating margin near 16.0%, while continuing to support our growth initiatives. We remain optimistic about leading market indicators across most of our businesses."

"We also announced the acquisitions of Amran Instrument Transformers and Narayan Powertech Pvt., Ltd. ("Amran/Narayan Group"), leading US and India based manufacturers of low to medium voltage transformers. This acquisition significantly expands our presence in the fast-growing, high-margin electrical grid end market, which will benefit from infrastructure upgrades, capacity expansion and data center demand. We anticipate this acquisition to be immediately accretive to revenue growth, EBITDA margin, operating margin, earnings per share and free cash flow. We are excited about our combined resources potential to accelerate growth in the electrical grid market."

"We remain confident about the secular trends in our defined fast growth end markets and for the added potential in the electrical grid market with the acquisition of the Amran/Narayan Group. In fiscal year 2024, our fast growth market sales grew 13% year-on-year to $94 million. In the fiscal first quarter 2025, sales from fast growth markets were relatively flat year-on-year, but we anticipate sequential and year-on-year improvement in the fiscal second quarter."

"In fiscal year 2025, based on recent order rates and customer interaction, we continue to expect our end markets to stabilize in the second quarter and strengthen in the second half. In the fiscal first quarter, we launched three new products and remain on track to release over a dozen new products in fiscal year 2025."

"Overall, we remain in a strong position for continued improvements in financial performance as market conditions improve. In terms of our balance sheet, we are confident in our ability to pay down debt and expect to reduce our net leverage ratio below 1.0x within the first 24 months from the closing of the Amran/Narayan Group."

Outlook

In the fiscal second quarter 2025, on a sequential basis, the Company expects moderately to significantly higher revenue, driven by the impact of the recent Amran/Narayan Group acquisition, more favorable project timing in Engraving, and improving overall demand in Electronics and Specialty. On a sequential basis, the Company expects slightly to moderately higher adjusted operating margin, benefiting from higher sales partially offset by increased investments in selling, marketing, and R&D. The Company also expects the Amran/Narayan Group acquisition to be slightly accretive to adjusted earnings per share in the fiscal second quarter 2025.

First Quarter Segment Operating Performance

Electronics (46% of sales; 48% of segment operating income)


                                              1Q25  1Q24  % Change




              Electronics ($M)



              Revenue                        77.7   81.7     -4.8 %



              GAAP Operating Income          17.0   16.3      4.2 %


    GAAP Operating Margin %                 21.9   20.0



              Adjusted Operating Income*     17.0   16.6      2.3 %



              Adjusted Operating Margin %*   21.9   20.4


     * Excludes purchase accounting expenses of $0.3M associated with Minntronix in Q1 FY24

Revenue decreased approximately $4.0 million or 4.8% year-on-year reflecting an 8.5% benefit from recent acquisitions and a 0.3% benefit from foreign currency, more than offset by an organic decline of 13.7%. The organic decline was due to continued softness in general industrial end markets in Europe, along with the effects of delays and prior overstocking related to certain large customer accounts. Adjusted operating income increased approximately $0.4 million or 2.3% year-on-year due to the contributions from recent acquisitions, productivity initiatives and product mix, partially offset by lower volume.

Electronics segment backlog realizable in under one year of approximately $93 million decreased 30% year-on-year. The segment had a book to bill ratio of 0.96 in the fiscal first quarter, with orders increasing 15% sequentially to approximately $75 million, the highest orders quarter in over a year.

In fiscal second quarter 2025, on a sequential basis, the Company expects significantly higher revenue, primarily driven by the recent Amran/Narayan Group acquisition and higher sales into fast growth end markets, and slightly to moderately higher adjusted operating margin, as the recent acquisition and pricing and productivity initiatives are partially offset by higher investments in selling, marketing, and R&D.

Engraving (20% of sales; 17% of segment operating income)


                                  1Q25  1Q24  % Change




              Engraving ($M)



              Revenue            33.4   40.8    -18.2 %



              Operating Income    5.8    7.6    -23.3 %


    Operating Margin %          17.5   18.6

Revenue decreased approximately $7.4 million or 18.2% year-on-year reflecting a 17.5% organic decline, primarily due to delays in new platform rollouts in North America and delays and general market softness in Europe, and a foreign currency impact of 0.7%. Operating income decreased approximately $1.8 million or 23.3% year-on-year due to the slower demand in North America and Europe. Operating deleverage was partially offset from the realization of previously announced productivity initiatives and restructuring actions.

In fiscal second quarter 2025, on a sequential basis, the Company expects moderately higher revenue and slightly higher operating margin due to more favorable project timing in Asia and Europe and productivity initiatives.

Scientific (10% of sales; 14% of segment operating income)


                                  1Q25  1Q24  % Change




              Scientific ($M)



              Revenue            17.7   18.2     -2.7 %



              Operating Income    4.7    4.9     -3.7 %


    Operating Margin %          26.8   27.1

Revenue decreased approximately $0.5 million or 2.7% year-on-year reflecting lower demand from retail pharmacies, partially offset by higher volume from new product sales. Operating income decreased approximately $0.2 million or 3.7% year-on-year as the impact of lower volume and higher freight costs were partially offset by productivity actions.

In fiscal second quarter 2025, on a sequential basis, the Company expects similar revenue and slightly lower operating margin due to R&D investments and higher freight costs.

Engineering Technologies (12% of sales; 11% of segment operating income)


                                               1Q25  1Q24  % Change




              Engineering Technologies ($M)



              Revenue                         20.5   18.2     12.7 %



              Operating Income                 4.0    3.0     32.9 %


    Operating Margin %                       19.5   16.6

Revenue increased approximately $2.3 million or 12.7% year-on-year primarily driven by more favorable project timing in the space end market which helped to drive growth in new product development and new applications. Operating income increased approximately $1.0 million or 32.9% year-on-year reflecting leverage on higher sales and pricing and productivity initiatives.

In fiscal second quarter 2025, on a sequential basis, the Company expects similar to slightly higher revenue due to new products and new applications and slightly lower operating margin due to product mix.

Specialty Solutions (12% of sales; 10% of segment operating income)


                                          1Q25  1Q24  % Change




              Specialty Solutions ($M)



              Revenue                    21.1   25.9    -18.3 %



              Operating Income            3.5    5.6    -36.8 %


    Operating Margin %                  16.8   21.7

Specialty Solutions revenue decreased approximately $4.7 million or 18.3% year-on-year, reflecting softness in the general market conditions in the Display Merchandising business and in the Hydraulics business. Operating income decreased approximately $2.1 million or 36.8% year-on-year due to lower volume.

In fiscal second quarter 2025, on a sequential basis, the Company expects slightly higher revenue and operating margin.

Capital Allocation

    --  Share Repurchase: During the fiscal first quarter 2025, the Company
        repurchased approximately 24,810 shares for $4.4 million. There was
        $28.9 million remaining on the Company's current share repurchase
        authorization at the end of the fiscal first quarter 2025.
    --  Capital Expenditures: In fiscal first quarter 2025, Standex's capital
        expenditures were $6.7 million compared to $4.3 million in the fiscal
        first quarter of 2024. The Company expects fiscal year 2025 capital
        expenditures between $35 million and $40 million. Capital expenditures
        were $20.3 million in fiscal 2024.
    --  Dividend: On October 24, 2024, the Company declared a quarterly cash
        dividend of $0.32 per share, an approximately 6.7% year-on-year
        increase. The dividend is payable November 22, 2024, to shareholders of
        record on November 8, 2024.

Balance Sheet and Cash Flow Highlights

    --  Net Debt: Standex had net (cash) debt of ($15.6) million on September
        30, 2024, compared to $16.4 million at the end of fiscal first quarter
        2024. Net (cash) debt for the first quarter of 2025 consisted primarily
        of long-term debt of $149.0 million and cash and equivalents of $164.6
        million.
    --  Cash Flow: Net cash provided by continuing operating activities for the
        three months ended September 30, 2024, was $17.5 million compared to
        $16.4 million in the prior year's quarter. Free cash flow after capital
        expenditures was $10.8 million compared to free cash flow after capital
        expenditures of $12.1 million in the fiscal first quarter of 2024.

Conference Call Details

Standex will host a conference call for investors today, October 29, 2024, at 10:00 a.m. ET. On the call, David Dunbar, President, and CEO, and Ademir Sarcevic, CFO, will review the Company's financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the "Investors" section of Standex's website under the subheading, "Events and Presentations," located at www.standex.com.

A replay of the webcast will also be available on the Company's website shortly after the conclusion of the presentation online through October 29, 2025. To listen to the teleconference playback, please dial in the U.S. (888) 660-6345 or (646) 517-4150 internationally; the passcode is 60631#. The audio playback via phone will be available through November 5, 2024. The webcast replay can be accessed in the "Investor Relations" section of the Company's website, located at www.standex.com.

Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles ("GAAP"), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures which include the impact of restructuring charges, purchase accounting, insurance recoveries, discrete tax events, gain or loss on sale of a business unit, acquisition costs, and litigation costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods. An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect. Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

About Standex

Standex International Corporation is a multi-industry manufacturer in five broad business segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. For additional information, visit the Company's website at http://standex.com/.

Forward-Looking Statements

Statements contained in this Press Release that are not based on historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as "should," "could," "may," "will," "expect," "believe," "estimate," "anticipate," "intend," "continue," or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company's business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of pandemics and other global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; increased costs from acquisitions to improve and coordinate managerial, operational, financial, and administrative systems, including internal controls over financial reporting and compliance with the Sarbanes-Oxley Act of 2002, and other costs related to such systems in connection with acquired businesses; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; the impact on our operations of any successful cybersecurity attacks; and potential changes to future pension funding requirements. For a more comprehensive discussion of these and other factors, see the "Risk Factors" section of the Company's most recent annual report on Form 10-K filed with the SEC and available on the Company's website. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.


                                                          
        
       Standex International Corporation


                                                        
        
       Consolidated Statement of Operations


                                                                                                            (unaudited)




                                                                                                                      Three Months Ended


                                                                                                                        September 30,



     (In thousands, except per share data)                                                                        2024                       2023





     Net sales                                                                                       $
            170,464                    184,774



     Cost of sales                                                                                             100,391                    112,139



     Gross profit                                                                                               70,073                     72,635





     Selling, general and administrative expenses                                                               43,048                     43,585



     (Gain) loss on sale of business                                                                                                       (274)



     Restructuring costs                                                                                         1,086                      1,906



     Acquisition related costs                                                                                   1,840                        501





     Income from operations                                                                                     24,099                     26,917





     Interest expense                                                                                              977                      1,276



     Other non-operating (income) expense, net                                                                    (28)                       846



     Total                                                                                                         949                      2,122





     Income from continuing operations before income taxes                                                      23,150                     24,795



     Provision for income taxes                                                                                  4,962                      5,903



     Net income from continuing operations                                                                      18,188                     18,892





     Income (loss) from discontinued operations, net of tax                                                          9                       (78)





     Net income                                                                                       $
            18,197               $
        18,814





     
                Basic earnings per share:



     Income (loss) from continuing operations                                                           $
            1.54                 $
        1.61



     Income (loss) from discontinued operations                                                                                           (0.01)



     Total                                                                                              $
            1.54                 $
        1.60





     
                Diluted earnings per share:



     Income (loss) from continuing operations                                                           $
            1.53                 $
        1.58



     Income (loss) from discontinued operations



     Total                                                                                              $
            1.53                 $
        1.58





     
                Average Shares Outstanding



        Basic                                                                                                   11,787                     11,742



        Diluted                                                                                                 11,904                     11,933


                                       
              
           Standex International Corporation


                                     
              
           Condensed Consolidated Balance Sheets


                                                  
         
                (unaudited)




                                                                                                    September 30,     June 30,



     (In thousands)                                                                                         2024          2024





     
                ASSETS



     Current assets:



       Cash and cash equivalents                                                               $
            164,584       154,203



       Accounts receivable, net                                                                          118,697       121,365



       Inventories                                                                                        90,121        87,106



       Prepaid expenses and other current assets                                                          73,745        67,421



         Total current assets                                                                            447,147       430,095





     Property, plant, equipment, net                                                                     138,373       134,963



     Intangible assets, net                                                                               78,957        78,673



     Goodwill                                                                                            292,180       281,283



     Deferred tax asset                                                                                   19,303        17,450



     Operating lease right-of-use asset                                                                   36,128        37,078



     Other non-current assets                                                                             25,794        25,515



         Total non-current assets                                                                        590,735       574,962





     Total assets                                                                            $
            1,037,882 $
      1,005,057





     
                LIABILITIES AND STOCKHOLDERS' EQUITY





     Current liabilities:



       Accounts payable                                                                         $
            66,505        63,364



       Accrued liabilities                                                                                52,885        56,698



       Income taxes payable                                                                                6,607         7,503



         Total current liabilities                                                                       125,997       127,565





     Long-term debt                                                                                      148,985       148,876



     Operating lease long-term liabilities                                                                29,722        30,725



     Accrued pension and other non-current liabilities                                                  75,157        76,388



         Total non-current liabilities                                                                   253,864       255,989





     Stockholders' equity:



       Common stock                                                                                       41,976        41,976



       Additional paid-in capital                                                                        108,383       106,193



       Retained earnings                                                                               1,100,924     1,086,277



       Accumulated other comprehensive loss                                                            (160,939)    (182,956)



       Treasury shares                                                                                 (432,323)    (429,987)



          Total stockholders' equity                                                                     658,021       621,503





     Total liabilities and stockholders' equity                                              $
            1,037,882 $
      1,005,057


                                       
              
                Standex International Corporation and Subsidiaries


                                             
              
                Statements of Consolidated Cash Flows


                                                          
              
                (unaudited)


                                                                                                                              Three Months Ended


                                                                                                                                 September 30,



     (In thousands)                                                                                                     2024                        2023





     
                Cash Flows from Operating Activities



     Net income                                                                                                   $
      18,197                      18,814



     Income (loss) from discontinued operations                                                                            9                        (78)



     Income from continuing operations                                                                                18,188                      18,892





     Adjustments to reconcile net income to net cash provided by operating activities:



     Depreciation and amortization                                                                                     7,061                       7,082



     Stock-based compensation                                                                                          2,568                       2,193



     Non-cash portion of restructuring charge                                                                          (143)                        397



     (Gain) loss on sale of business                                                                                                              (274)



     Contributions to defined benefit plans                                                                          (3,379)                       (49)



     Net changes in operating assets and liabilities                                                                 (6,748)                   (11,834)



     Net cash provided by operating activities - continuing operations                                                17,547                      16,407



     Net cash provided by (used in) operating activities - discontinued operations                                        26                       (227)



     Net cash provided by (used in) operating activities                                                              17,573                      16,180



     
                Cash Flows from Investing Activities



         Expenditures for property, plant and equipment                                                              (6,725)                    (4,338)



         Expenditures for acquisitions, net of cash acquired                                                                                   (29,229)



         Proceeds from the sale of business                                                                                                         274



         Other investing activities                                                                                      411



     Net cash provided by (used in) investing activities                                                             (6,314)                   (33,293)



     
                Cash Flows from Financing Activities



         Payments of debt                                                                                                                      (25,000)



         Activity under share-based payment plans                                                                      1,637                         768



         Purchase of treasury stock                                                                                  (4,382)                   (22,158)



         Cash dividends paid                                                                                         (3,528)                    (3,288)



     Net cash provided by (used in) financing activities                                                             (6,273)                   (49,678)





     Effect of exchange rate changes on cash                                                                           5,395                     (2,085)





     Net changes in cash and cash equivalents                                                                         10,381                    (68,876)



     Cash and cash equivalents at beginning of year                                                                  154,203                     195,706



     Cash and cash equivalents at end of period                                                                  $
      164,584         $
              126,830


                          
              
            Standex International Corporation


                                
             
             Selected Segment Data


                                     
          
                (unaudited)




                                                                                       Three Months Ended


                                                                                          September 30,



     (In thousands)                                                              2024                        2023



     
                Net Sales



     Electronics                                                   $
              77,733          $
              81,688



     Engraving                                                                 33,363                      40,794



     Scientific                                                                17,693                      18,193



     Engineering Technologies                                                  20,530                      18,220



     Specialty Solutions                                                       21,145                      25,879



     Total                                                        $
              170,464         $
              184,774





     
                Income from operations



     Electronics                                                   $
              17,027          $
              16,334



     Engraving                                                                  5,824                       7,595



     Scientific                                                                 4,749                       4,930



     Engineering Technologies                                                   4,010                       3,017



     Specialty Solutions                                                        3,548                       5,617



     Restructuring                                                            (1,086)                    (1,906)



     Gain (loss) on sale of business                                                                         274



     Acquisition related costs                                                (1,840)                      (501)



     Corporate                                                                (8,133)                    (8,443)



     Total                                                         $
              24,099          $
              26,917


                                                                                                     
        
               Standex International Corporation


                                                                                           
              
         Reconciliation of GAAP to Non-GAAP Financial Measures


                                                                                                          
             
                (unaudited)




                                                                                                                                                                                                 Three Months Ended


                                                                                                                                                                                                   September 30,



     (In thousands, except percentages)                                                                                                                                 2024                 2023                                 %
                                                                                                                                                                                                                    Change



     
                Adjusted income from operations and adjusted net income from continuing operations:



     
                Net Sales                                                                                                                                      $
      170,464         $
       184,774                            -7.7 %



     
                Income from operations, as reported                                                                                                             $
      24,099          $
       26,917                           -10.5 %


                                                                                                        
         Income from operations margin                                    14.1 %                                       14.6 %



     Adjustments:


                                                                                                        
         Restructuring charges                                             1,086                                         1,906


                                                                                                        
         Acquisition-related costs                                         1,840                                           501


                                                                                                        
         (Gain) loss on sale of business                                                                                (274)


                                                                                                        
         Purchase accounting expenses                                                                                     340



     
                Adjusted income from operations                                                                                                                 $
      27,025          $
       29,390                            -8.0 %


                                                                                                        
         Adjusted income from operations margin                           15.9 %                                       15.9 %


                                                                                                        
         Interest and other income (expense), net                          (949)                                      (2,122)


                                                                                                        
         Provision for income taxes                                      (4,962)                                      (5,903)


                                                                                                        
         Discrete and other tax items                                       (72)                                          100


                                                                                                        
         Tax impact of above adjustments                                   (702)                                        (654)



     
                Net income from continuing operations, as adjusted                                                                                              $
      20,340          $
       20,811                            -2.3 %





     
                EBITDA and Adjusted EBITDA:



     
                Net income (loss) from continuing operations, as reported                                                                                       $
      18,188          $
       18,892                            -3.7 %


                                                                                                        
         Net income from continuing operations margin                     10.7 %                                       10.2 %



     Add back:


                                                                                                        
         Provision for income taxes                                        4,962                                         5,903


                                                                                                        
         Interest expense                                                    977                                         1,276


                                                                                                        
         Depreciation and amortization                                     7,061                                         7,082



     
                EBITDA                                                                                                                                          $
      31,188          $
       33,153                            -5.9 %


                                                                                                        
         EBITDA Margin                                                    18.3 %                                       17.9 %



     Adjustments:


                                                                                                        
         Restructuring charges                                             1,086                                         1,906


                                                                                                        
         Acquisition-related costs                                         1,840                                           501


                                                                                                        
         (Gain) loss on sale of business                                                                                (274)


                                                                                                        
         Purchase accounting expenses                                                                                     340



     
                Adjusted EBITDA                                                                                                                                 $
      34,114          $
       35,626                            -4.2 %


                                                                                                        
         Adjusted EBITDA Margin                                           20.0 %                                       19.3 %





     
                Free operating cash flow:



     
                Net cash provided by operating activities - continuing operations, as reported                                                                  $
      17,547          $
       16,407



     Less: Capital expenditures                                                                                                                                      (6,725)             (4,338)



     
                Free cash flow from continuing operations                                                                                                       $
      10,822          $
       12,069


                                                                                         
            
                Standex International Corporation


                                                                                     
        
              Reconciliation of GAAP to Non-GAAP Financial Measures


                                                                                                  
              
                (unaudited)




                                                                                                                                                                                            Three Months Ended



     
                Adjusted earnings per share from continuing operations                                                                                     September 30,


                                                                                                                                 2024                                          2023                               %
                                                                                                                                                                                                           Change





     
                Diluted earnings per share from continuing operations, as reported                                                                      $
              1.53         $
     1.58                           -3.2 %





     Adjustments:


                                                                                       
        Restructuring charges                                                             0.07                                     0.12


                                                                                       
        Acquisition-related costs                                                         0.12                                     0.03


                                                                                       
        (Gain) loss on sale of business                                                                                         (0.02)


                                                                                       
        Discrete tax items                                                              (0.01)                                    0.01


                                                                                       
        Purchase accounting expenses                                                                                              0.02



     
                Diluted earnings per share from continuing operations, as adjusted                                                                      $
              1.71         $
     1.74                           -1.7 %

View original content to download multimedia:https://www.prnewswire.com/news-releases/standex-reports-fiscal-first-quarter-2025-financial-results-302289865.html

SOURCE Standex International Corporation